More information
Description
This initiative aims to exchange expertise and strengthen capacity in addiction/pharmacoepidemiological registry-based research and to explore the potential for a joint research project on the psychoactive prescription medication use. The main objective is to promote research excellence and collaboration between the Czech Republic and Norway and to foster a mutually beneficial partnership.
Summary of the results
This initiative successfully met its three main objectives including scientific findings. Through study visits and structured collaboration with Norwegian partners, participants gained advanced skills in data management, record linking, and complex statistical methods. Czech researchers notably deepened their expertise in opioid drug utilization studies. These activities were driven by multiple case studies involving both Czech and Norwegian teams, ensuring practical and context-relevant training (in particular: Case study I. – Mortality of long-term opioid prescription users in Norway, Case study II. – Trends in prescribed opioid analgesic dispensation in Norway, Denmark, and Sweden, 2010–2022, Case study III. – Studying epidemiological indicators (mortality and morbidity) among children and young people with substance use disorders (SUDs) using Czech health registry data, and Case study IV. – Studying COVID-19 outcomes in individuals in opioid agonist treatment using Czech health registry data).